Takagi A, Yabe Y, Oka Y, Sawai K, Takakura Y, Hashida M
Department of DDS Research, Novel Pharma Research Laboratories, Yamanouchi Pharmaceutical Co., Ltd., Ozumi Yaizu, Shizuoka, Japan.
Pharm Res. 1997 Jan;14(1):86-90. doi: 10.1023/a:1012063602856.
To clarify the mechanism of the renal clearance of recombinant human interleukin- 11 (rhIL- 1), we investigated the renal disposition characteristics of rhIL-11 in the perfused rat kidney.
The disposition characteristics of (111)In-labeled rhIL-11 were analyzed using a single-pass indicator dilution technique and statistical moment analysis in the perfused rat kidney under filtering and nonfiltering conditions.
Steady-state distribution volume (Vd) calculated from the venous outflow patterns of rhIL-11 at the doses of 0.3 to 10 microg/kidney was between 0.35 and 0.40 ml/g kidney. However, Vd at the highest dose decreased to a value almost identical to that of bovine serum albumin, suggesting that there is a reversible and saturable interaction between the capillary wall and rhIL-11 molecule. In filtering kidney, a remarkable accumulation of rhIL-11 was observed while its urinary excretion was highly restricted at all doses. In nonfiltering kidney, rhIL-11 showed a decreased but still significant renal uptake. Taken together, the marked renal uptake of rhIL-11 may be explained by both efficient tubular reabsorption and significant uptake from the capillary side. These processes were not saturable within the tested dose range. These characteristics of rhIL-11 are likely based on non-specific electrostatic interaction with the tissues due to its cationic charge in the cytokine.
The renal disposition processes of rhIL-11 were clarified at organ level in a quantitative manner. These findings agree well with previous observations in an in vivo disposition study in mice.
为阐明重组人白细胞介素-11(rhIL-11)的肾脏清除机制,我们研究了rhIL-11在灌注大鼠肾脏中的处置特征。
采用单通道指示剂稀释技术和统计矩分析法,在灌注大鼠肾脏的过滤和非过滤条件下,分析¹¹¹In标记的rhIL-11的处置特征。
在剂量为0.3至10μg/肾时,根据rhIL-11的静脉流出模式计算出的稳态分布容积(Vd)在0.35至0.40ml/g肾脏之间。然而,最高剂量时的Vd降至与牛血清白蛋白几乎相同的值,表明毛细血管壁与rhIL-11分子之间存在可逆且可饱和的相互作用。在过滤肾脏中,观察到rhIL-11有明显蓄积,而其在所有剂量下的尿排泄均受到高度限制。在非过滤肾脏中,rhIL-11的肾脏摄取减少但仍很显著。综合来看,rhIL-11明显的肾脏摄取可能是由于有效的肾小管重吸收和从毛细血管侧的显著摄取共同作用的结果。在测试剂量范围内,这些过程不饱和。rhIL-11的这些特征可能是由于其细胞因子中的阳离子电荷与组织发生非特异性静电相互作用所致。
以定量方式在器官水平阐明了rhIL-11的肾脏处置过程。这些发现与先前在小鼠体内处置研究中的观察结果非常吻合。